Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Alzheimer’s Association joins the world in mourning the loss of former President Ronald Reagan

The Alzheimer’s Association joins the world in mourning the loss of former President of the United States Ronald Reagan. Our heart-felt condolences go out to the Reagan family.

6 Jun 2004

Parkinson's disease breakthrough

Brandeis scientists have made groundbreaking advances in understanding how the regulations of a novel gene during the cell cycle can lead to a rare familial case of the early onset of Parkinson's disease.

5 Jun 2004

An insight into caring for dementia in particular 'aggressive dementia'

By the age of 65 one out of every ten persons has some form of dementia, and by the age of 85 (the fastest growing segment of the population), one out of every two. Statistically families (and many doctors who are not dementia specialists) ignore the early warning signs because they incorrectly believe that the odd behaviors are just a normal part of aging and untreatable senility.

27 May 2004

Cellular garbage plays a key role in the process of cytokinesis, or cell division

A cellular structure discovered 125 years ago and dismissed by many biologists as "cellular garbage" has been found to play a key role in the process of cytokinesis, or cell division, one of the most ancient and important of all biological phenomena.

27 May 2004

₤16.5 million investment in stem cell research

A ₤16.5 million investment in stem cell research was announced today, 27th May, promising to speed the development of new treatments and cures from the laboratory to the clinic. In total, 57 multidisciplinary research grants have been awarded as part of the new monies allocated via the 2002 Government Spending Review to the UK Research Councils.

27 May 2004

30-ton superconducting magnet to further brain research

The 30-ton, superconducting magnet that forms the center of a 7-Tesla MRI (magnetic resonance imaging) system developed by Siemens Medical Solutions will be uncrated and moved by crane from a truck into the New York University School of Medicine’s Center for Biomedical Imaging this Friday morning.

26 May 2004

Data suggests potential target for Alzheimer's disease treatment

Researchers from Weill Cornell Medical College and Columbia University College of Physicians & Surgeons have discovered at least one way in which beta-amyloid, the protein that forms stubborn plaques in the brains of Alzheimer's disease patients, can kill nerve cells.

25 May 2004

Columbia University to study link between diabetes and early dementia

Understanding the link between diabetes and early dementia -- as well as how diabetes relates to other causes of memory loss -- is the focus of a new study at Columbia University Medical Center and approximately 40 other medical institutions nationwide.

25 May 2004

Link between diabetes and early dementia

25 May 2004

A new guideline evaluates the treatment of infantile spasms

A new guideline developed by the American Academy of Neurology and the Child Neurology Society evaluates the treatment of infantile spasms. The guideline is published in the May 25 issue of Neurology, the scientific journal of the American Academy of Neurology.

24 May 2004

People with low incomes are more likely to develop brain cancer

People with low incomes are more likely to develop brain cancer, according to a study published in the May 25 issue of Neurology, the scientific journal of the American Academy of Neurology.

24 May 2004

Are we as crazy as mad cows?

When proteins in our body work properly, we can see, smell, consume and digest food, grow muscle and brain cells. But when these infinitely useful biological building blocks fail, the most pernicious diseases arise. Susan Lindquist has scrutinized the complex origami-like shapes of proteins and come to understand how structural mistakes can lead to a frightening class of neurodegenerative disorders, including “Mad Cow Disease.”

20 May 2004

Natural biological process by which yeast cells dismantle amyloid fibers

Amyloid fibers, those clumps of plaque-like proteins that clog up the brains of Alzheimer's patients, have perplexed scientists with their robust structures. In laboratory experiments, they are able to withstand extreme heat and cold and powerful detergents that cripple most other proteins.

20 May 2004

Protein that appears to play a key role in Alzheimer's disease

A protein that allows human cancer to resist multiple anticancer drugs also appears to play a key role in Alzheimer's disease, according to research conducted at Fox Chase Cancer Center. The protein, active in brain tissue, could be a target for new drugs to treat patients with Alzheimer's.

20 May 2004

Researchers to study link between diabetes and early dementia

Understanding the link between diabetes and early dementia – as well as how diabetes relates to other causes of memory loss – is the focus of a new study at Columbia University Medical Center (CUMC) and approximately 40 other medical institutions nationwide.

20 May 2004

Centre for Life opens with the UK’s first two human embryonic stem cell lines

The UK’s first two human embryonic stem cell lines, developed separately by researchers at King’s College London and the Centre for Life in Newcastle, are to be deposited in the UK Stem Cell Bank. The deposit coincides with the official opening of the Bank by Health Minister, Lord Warner, today (Wednesday 19 May 2004).

19 May 2004

50 new scientists sought after in the field of biomedical research

The Institute is looking for candidates from the full range of biological and biomedical inquiry who demonstrate exceptional promise early in their careers as independent researchers. Nearly 200 universities, medical schools, and research institutes have been invited to nominate their best scientists for the competition. Between 30 and 50 scientists will be chosen to join the Institute in 2005.

19 May 2004

1.3 million Hispanics will have Alzheimer’s disease by 2050

Alzheimer’s disease and related dementias are projected to increase more than six-fold among Hispanics in the U.S. during the first half of the 21st century, according to a new report released today by the Alzheimer’s Association. This increase means that 1.3 million Hispanics will have Alzheimer’s disease by 2050, compared to fewer than 200,000 currently living with the disease.

17 May 2004

Scientists move closer toward treatment for degenerative diseases

Scientists at McGill University's Faculty of Medicine have discovered a key step that will provide new targets for treatments of many degenerative diseases such as Alzheimer's, Cystic Fibrosis and Diabetes.

17 May 2004

$1.4 million to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier

The Cleveland Clinic has been awarded a four-year, $1.4 million grant from the National Institutes of Health to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier. Researchers hope to use their findings to develop new methods to limit the damage caused by such events.

17 May 2004